Quidel Corp. (QDEL) PT Raised to $27 at Barclays; Reiterates Overweight
Tweet
Share
E-mailGet Alerts QDEL Hot Sheet
Price: $14.13 +0.28%
Rating Summary:
7 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
7 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Barclays raised its price target on Quidel Corp. (NASDAQ: QDEL) to $27.00 (from $26.00) while maintaining a Overweight rating. QDEL reported 1Q revenues of $73.7 million, beating estimates of $62.4 million by 18%. The beat was driven by a more aggressive-than-expected flu season.
Analyst Jack Meehan believes that the company's innovation in point-of-care testing fits well into broader trends related to healthcare consumerism.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR18 at JPMorgan
- McGraw Hill (MH) PT Lowered to $14 at UBS on Softer 2027 Outlook
- Datadog (DDOG) PT Raised to $260 at BMO Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
